Ricolinostat enhances adavosertib-induced mitotic catastrophe in TP53-mutated head and neck squamous cell carcinoma cells

TP53 mutation is one of the most frequent gene mutations in head and neck squamous cell carcinoma (HNSCC) and could be a potential therapeutic target. Recently, the WEE1 G2 checkpoint kinase (WEE1) inhibitor adavosertib (Adv) has attracted attention because of its selective cytotoxicity against TP53...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyake, Keitaro, Takano, Naoharu, Kazama, Hiromi, Kikuchi, Hiroyuki, Hiramoto, Masaki, Tsukahara, Kiyoaki, Miyazawa, Keisuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997343/
https://www.ncbi.nlm.nih.gov/pubmed/35348191
http://dx.doi.org/10.3892/ijo.2022.5344

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997343/
https://www.ncbi.nlm.nih.gov/pubmed/35348191
http://dx.doi.org/10.3892/ijo.2022.5344

Ejemplares similares